Adiposity and eating behaviors in patients under second generation antipsychotics

Obesity

Volumn 16, Issue 8, 2008, Pages 1780-1787

  Blouin, Mélissa ^a,b   Tremblay, Angelo ^b   Jalbert, Marie Eve ^a   Venables, Hélène ^a   Bouchard, Roch Hugo ^c   Roy, Marc André ^c   Alméras, Natalie ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48749084870     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.277     Document Type: Article

References (40)

1. Bouchard RH, Mérette C, Pourcher E et al. Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Québec Schizophrenia Study Group. J Clin Psychopharmacol 2000;20:295-304.
2. Allison DB, Mentore JL, Heo M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-1696.
3. Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 2004;70:1-17.
4. Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 2004;64:701-723.
5. Alméras N, Després JP, Villeneuve J et al. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry 2004;65:557-564.
6. Ritsner M, Ponizovsky A, Endicott J et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002;12:31-38.
7. Olfson M, Mechanic D, Hansell S et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000;51:216-222.
8. Costa e Silva JA, Alvarez N, Mazzotti G et al. Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America. J Clin Psychopharmacol 2001;21:375-381.
9. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl 1989:59-67.
10. Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry 1995;166:654-659.
11. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000;101:323-329.
12. Addington D, Addington J, Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics. Schizophr Res 1994;11:239-244.
13. Lohman TG, Roche AF, Martorell R. Skinfold thicknesses and measurement technique. In: Anthropometric Standardization Reference Manual. Human Kinetics Books: Champaign, IL, 1988, pp 55-80.
14. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 1993;17:187-196.
15. Nord RH, Homuth JR, Hanson JA, Mazess RB. Evaluation of a new DXA fan-beam instrument for measuring body composition. Ann NY Acad Sci 2000;904:118-125.
16. Ferland M, Després JP, Tremblay A et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 1989;61:139-148.
17. Paré A, Dumont M, Lemieux I et al. Is the relationship between adipose tissue and waist girth altered by weight loss in obese men? Obes Res 2001;9:526-534.
18. Health and Welfare Canada. Canadian Nutrient File. Tape and User's Guide. no. 58-42-1997E-MRed. Health and Welfare Canada: Ottawa, 1997.
19. Hill AJ. Macronutrients and satiety: the effects of a high protein or high carbohydrate meal on subjective motivation to eat and food preferences. Nutr Behav 1986;3:133-144.
20. Kissileff HR. Satiating efficiency and a strategy for conducting food loading experiments. Neurosci Biobehav Rev 1984;8:129-135.
21. Green SM, Delargy HJ, Joanes D, Blundell JE. A satiety quotient: a formulation to assess the satiating effect of food. Appetite 1997;29:291-304.
22. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83.
23. Bond MJ, McDowell AJ, Wilkinson JY. The measurement of dietary restraint, disinhibition and hunger: an examination of the factor structure of the Three Factor Eating Questionnaire (TFEQ). Int J Obes Relat Metab Disord 2001;25:900-906.
24. Drapeau V, Blundell J, Therrien F et al. Appetite sensations as a marker of overall intake. Br J Nutr 2005;93:273-280.
25. Provencher V, Drapeau V, Tremblay A, Després JP, Lemieux S. Eating behaviors and indexes of body composition in men and women from the Québec family study. Obes Res 2003;11:783-792.
26. Kroeze WK, Hufeisen SJ, Popadak BA et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 2003;28:519-526.
27. Sysko R, Devlin MJ, Walsh BT, Zimmerli E, Kissileff HR. Satiety and test meal intake among women with binge eating disorder. Int J Eat Disord 2007;40:554-561.
28. Laessle RG, Tuschl RJ, Kotthaus BC, Pirke KM. A comparison of the validity of three scales for the assessment of dietary restraint. J Abnorm Psychol 1989;98:504-507.
29. Tuschl RJ. From dietary restraint to binge eating: some theoretical considerations. Appetite 1990;14:105-109.
30. Westerterp-Plantenga MS, Wouters L, ten Hoor F. Restrained eating, obesity, and cumulative food intake curves during four-course meals. Appetite 1991;16:149-158.
31. Westenhoefer J, Stunkard AJ, Pudel V. Validation of the flexible and rigid control dimensions of dietary restraint. Int J Eat Disord 1999;26:53-64.
32. McGuire MT, Jeffery RW, French SA, Hannan PJ. The relationship between restraint and weight and weight-related behaviors among individuals in a community weight gain prevention trial. Int J Obes Relat Metab Disord 2001;25:574-580.
33. Westenhoefer J. Dietary restraint and disinhibition: is restraint a homogeneous construct? Appetite 1991;16:45-55.
34. Williamson DA, Lawson OJ, Brooks ER et al. Association of body mass with dietary restraint and disinhibition. Appetite 1995;25:31-41.
35. Polivy J. Psychological consequences of food restriction. J Am Diet Assoc 1996;96:589-592.
36. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29:697-701.
37. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003;183:534-539.
38. McCreadie RG, Kelly C, Connolly M et al. Dietary improvement in people with schizophrenia: randomised controlled trial. Br J Psychiatry 2005;187:346-351.
39. Peet M. Diet, diabetes and schizophrenia: review and hypothesis. Br J Psychiatry Suppl 2004;47:S102-S105.
40. Strassnig M, Brar JS, Ganguli R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003;29:393-397.